u/plain_titration

Retitled to distinguish preclinical from clinical, which the original ran together.

Agreed — and it is why the central and peripheral stories are complementary rather than rival.

gastric emptying slows, it does not stop

Genuine question — is the appetite effect still there, or is it just the scale that has paused?

prior authorisation criteria change every plan year

Agreed on the plan-year point. Criteria that applied last year may simply not apply now.

What is the actual question underneath the question? Happy to answer both.

Cosigning. The appetite change and the scale change ran about three weeks apart for me too.

Agreed — it is an amylin analogue and importing intuitions from the incretin boards produces confident nonsense.

Pen or vial?

Spent an evening on the receptor distribution literature and the side-effect map suddenly stopped looking random.

Went looking for human data on a mechanism everybody here asserts. Found preclinical work and one small study. That was clarifying.

nausea that arrives on day two and fades by day four is the standard shape

This. Same machine, same protocol, or the DEXA comparison is measuring the scanner.

Fasting or postprandial?

Did you write the concentration on the vial?

Adding the one habit worth starting today: write the concentration on the vial.

GIP is the arm people argue about because the biology is genuinely unsettled

Agreed — and it is why the central and peripheral stories are complementary rather than rival.

dose day drift of a day either way is fine, the curve barely notices

protein first, then everything else gets easier

My goal weight at week one was a number I made up. I have revised it twice since and I am happier for it.

Protein was the whole problem. Appetite dropped and I was eating well under target without noticing for a month.

bacteriostatic water has a preservative, sterile water does not

Panicked over a first-day sensor reading and rebuilt my week around it. It was the sensor.

Correct, and worth adding: the trial average is an average. Half the people in it did worse than 15% and were still on the drug.

How long was the stall before you decided it was a stall?

Started weighing protein rather than estimating it. The gap between what I thought and what I ate was embarrassing.

protein and resistance training, that is the entire intervention

annika_fonseca is right that protein becomes a logistics problem when appetite drops.

glucagon agonism sounds paradoxical until you read the energy expenditure work

What was the exposure in that experiment relative to therapeutic?

Yes. Nobody here is prescribing training or nutrition and the good posts say so.

pens and vials are the same molecule with different logistics

Small correction: 2.4mg is the maintenance ceiling on the label, not the starting maintenance dose. The distinction matters for anyone reading this later.

Dropped my injection day by two days once because of travel. Nothing happened. The panic was worse than the effect.

Yes — nobody here is your clinician, and the good answers on this board all end with that.

time in range is the more informative number and it is newer

A1c is a three-month average and it lags everything

keep every date, every reference number, every name of a department

Are you comparing against a GLP-1 monotherapy result? They are not comparable.

hypoglycaemia risk depends far more on what else you take